Animal models for evaluation of influenza vaccines

Current Topics in Microbiology and Immunology

Volumn 333, Issue 1, 2009, Pages 397-412

  Tripp, Ralph A ^a   Tompkins, S Mark ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; IMMUNOGLOBULIN A; INFLUENZA VACCINE; LIVE VACCINE; SUBUNIT VACCINE; TRIPLE VACCINE;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS; NONHUMAN; PANDEMIC INFLUENZA; PRIMATE; PRIORITY JOURNAL; REVIEW; SEASONAL INFLUENZA; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS TRANSMISSION;

ANIMALIA; ORTHOMYXOVIRIDAE;

EID: 77749300939     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-92165-3_19     Document Type: Review

References (92)

1. Aleksandrova GI, Medvedeva TE, Polezhaev FI, Garmashova LM, Budilovskii GN (1986) Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57. Vopr Virusol 31:411-414
2. Ambrose CS, Walker RE, Connor EM (2006) Live attenuated influenza vaccine in children. Semin Pediatr Infect Dis 17:206-212
3. Anderson AO, Swearengen JR (2006) Scientific and ethical importance of animal models in biodefense research. CRC, Boca Raton
4. Andrewes CH, Laidlaw PP, Smith W (1934) The susceptibility of mice to the virus of human and swine influenza. Lancet 224:859-862
5. Barry DW, Staton E, Mayner RE (1974) Inactivated influenza vaccine efficacy: diminished anti-genicity of split-product vaccines in mice. Infect Immun 10:1329-1336
6. Baum LG, Paulson JC (1990) Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 40:35-38
7. Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM (2004) Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines 3:643-654
8. Berendt RF (1974) Simian model for the evaluation of immunity to influenza. Infect Immun 9:101-105
9. Berendt RF, Hall WC (1977) Reaction of squirrel monkeys to intratracheal inoculation with influenza/A/New Jersey/76. (swine) virus. Infect Immun 16:476-479
10. Block SL (2004) Role of influenza vaccine for healthy children in the US. Paediatr Drugs 6:199-209
11. Branch I. (ed). (2008) US flu activity report for week ending March 1. (Week 9), posted March 7. Centers for Disease Control and Prevention, Atlanta
12. Bridges C, Kuehnert M, Hall C (2003) Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37:1094-1101
13. Burnet FM (1940a) Influenza virus infections of the chick embryo lung. Br J Exp Path 21:147-153
14. Burnet FM (1940b) Virus infections of the chick embryo by the amniotic route. 1. General character of the infections. Aust J Exp Biol Med Sci 18:353-360
15. Burnet FM (1941) Growth of influenza virus in the allantoic cavity of the chick embryo. Aust J Exp Biol Med Sci 19:291-295
16. Clyde WA Jr (1980) Experimental models for study of common respiratory viruses. Environ Health Perspect 35:107-112
17. Dean HJ (2005) Epidermal delivery of protein and DNA vaccines. Expert Opin Drug Deliv 2:227-236
18. Desheva Iu A, Danini G V, Grigor'eva EP, Donina SA, Kiseleva I V, Rekstin AR, Ermakova LA, Natsina VK, Nikolaeva VM, Lonskaia NI, El'shina GA, Zhavoronkov VG, Drinevskii VP, Erofeeva MK, Naikhin AN, Rudenko LG (2002) The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children. Vopr Virusol 47:21-24
19. Donnelly JJ, Ulmer JB, Liu MA (1994) Immunization with DNA. J Immunol Methods 176:145-152
20. Eichelberger MC (2007) The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol 20:243-249
21. Epstein SL (2003) Control of influenza virus infection by immunity to conserved viral features. Expert Rev Anti Infect Ther 1:627-638
22. Epstein SL (2006) Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 193:49-53
23. Eyler JM (2006) De Kruif's boast: vaccine trials and the construction of a virus. Bull Hist Med 80:409-438
24. Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies ME, Liao J, Emini EA, Shiver JW (2004) Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22:2993-3003
25. FDA (2007) Product approval information, influenza virus vaccine, H5N1. Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Rockville
26. Fiers W, De Filette M, Birkett A, Neirynck S, Min Jou W (2004) A "universal" human influenza A vaccine. Virus Res 103:173-176
27. Francis T Jr (1934) Transmission of influenza by a filterable virus. Science 80:457-459
28. Francis T (1937) Epidemiological studies in influenza. Am J Public Health Nations Health 27:211-225
29. Francis T (1953) Vaccination against influenza. Bull WHO 8:725-741
30. Glezen WP (2006) Herd protection against influenza. J Clin Virol 37:237-243
31. Heath AW, Addison C, Ali M, Teale D, Potter CW (1983) In vivo and in vitro hamster models in the assessment of virulence of recombinant influenza viruses. Antiviral Res 3:241-252
32. Herlocher ML, Elias S, Truscon R, Harrison S, Mindell D, Simon C, Monto A (2001) Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. J Infect Dis 184:542-546
33. Hilleman MR (1977) Serologic responses to split and whole swine influenza virus vaccines in the light of the next influenza pandemic. J Infect Dis 136:S683-S685
34. Hilleman MR, Mason RP, Buescher EL (1950) Antigenic pattern of strains of influenza A and B. Proc Soc Exp Biol Med 75:829-835
35. Hirst GK (1942) Adsorption of influenza hemagglutinins and virus by red blood cells. J Exp Med 76:195-209
36. Hirst GK (1943) Studies of antigenic differences among strains of influenza A by means of red cell agglutination. J Exp Med 78:407-423
37. Hirst GK (1947a) Comparison of influenza virus strains from three epidemics. J Exp Med 86:367-381
38. Hirst GK (1947b) Studies on the mechanism of adaptation of influenza virus to mice. J Exp Med 86:357-366
39. Horsfall FL Jr, Lennette EH, Rickard ER (1941) A complex vaccine against influenza A virus: quantitative analysis of the antibody response produced by man. J Exp Med 73:335-355
40. Iida T, Bang FB (1963) Infection of the upper respiratory tract of mice with influenza A virus. Am J Epidemiol 77:169-176
41. Jan C, De Jong WE (2000) Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61:94-99
42. Kendal AP (1997a) Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries. Eur J Epidemiol 13:591-609
43. Kendal AP (1997b) Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur J Epidemiol 13:591-609
44. Kilbourne ED (1976) Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. J Infect Dis 134:384-394
45. Klimov AI, Egorov AY, Gushchina MI, Medvedeva TE, Gamble WC, Rudenko LG, Alexandrova GI, Cox NJ (1995) Genetic stability of cold-adapted A/Leningrad/134/47/57. (H2N2) influenza virus: sequence analysis of live cold-adapted reassortant vaccine strains before and after replication in children. J Gen Virol 76(Pt 6):1521-1525
46. Laddy DJ, Weiner DB (2006) From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 25:99-123
47. Leigh MW, Cheng PW, Boat TF (1989) Developmental changes of ferret tracheal mucin composition and biosynthesis. Biochemistry 28:9440-9446
48. Leigh MW, Connor RJ, Kelm S, Baum LG, Paulson JC (1995) Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine 13:1468-1473
49. Lipatov A, Hoffmann E, Salomon R, Yen H-L, Webster R (2006) Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/ Vietnam/1203/04(H5N1) virus in ferrets. J Infect Dis 194:1040-1043
50. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P (2006) The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 103:9988-9992
51. Lynch JP 3rd, Walsh EE (2007) Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med 28:144-158
52. Maassab H, Herlocher ML, Bryant ML (1999) Live influenza vaccines. In: Plotkin OW, Mortimer SA. (ed) Vaccines. Saunders, Philadelphia, pp 909-927
53. Maher JA, DeStefano J (2004) The ferret: an animal model to study influenza virus. Lab Anim. (NY) 33:50-53
54. Maines TR, Chen LM, Matsuoka Y, Chen H, Rowe T, Ortin J, Falcon A, Nguyen TH, Mai le Q, Sedyaningsih ER, Harun S, Tumpey TM, Donis RO, Cox NJ, Subbarao K, Katz JM (2006) Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci USA 103:12121-12126
55. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk H-D (2004) Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 101:4620-4624
56. Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA (1993) Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 12:777-783
57. Murphy BR, Sly DL, Hosier NT, London WT, Chanock RM (1980) Evaluation of three strains of influenza A virus in humans and in owl, cebus, and squirrel monkeys. Infect Immun 28:688-691
58. Murphy BR, Hinshaw VS, Sly DL, London WT, Hosier NT, Wood FT, Webster RG, Chanock RM (1982a) Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun 37:1119-1126
59. Murphy BR, Sly DL, Tierney EL, Hosier NT, Massicot JG, London WT, Chanock RM, Webster RG, Hinshaw VS (1982b) Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys. Science 218:1330-1332
60. Murphy BR, Harper J, Sly DL, London WT, Miller NT, Webster RG (1983) Evaluation of the A/ Seal/Mass/1/80 virus in squirrel monkeys. Infect Immun 42:424-426
61. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W (1999) A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5:1157-11563
62. Nichol KL (2001) Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 19:4373-4377
63. Novak M, Moldoveanu Z, Schafer DP, Mestecky J, Compans RW (1993) Murine model for evaluation of protective immunity to influenza virus. Vaccine 11:55-60
64. Ottolini MG, Blanco JCG, Eichelberger MC, Porter DD, Pletneva L, Richardson J Y, Prince GA (2005) The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J Gen Virol 86:2823-2830
65. Palese P, Shaw ML (2006) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DM, Lamb RA, Martin MA. (eds) Field's virology. Lippincott, Williams & Wilkins, Philadelphia, pp 1647-1689
66. Parkman PD, Hopps HE, Rastogi SC, Meyer H (1977) Summary of clinical trials of influenza virus vaccines in adults. J Infect Dis 136:S722-S730
67. Piazza FM, Carson JL, Hu SC, Leigh MW (1991) Attachment of influenza A virus to ferret tracheal epithelium at different maturational stages. Am J Respir Cell Mol Biol 4:82-87
68. Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP (2005) Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 116:e397-e407
69. Rasmussen AF, Stokes JC, Smadel JE (1948) The army experience with influenza 1946-1947. Part II. Laboratory aspects. Am J Hyg 47:142-149
70. Rudenko LG, Slepushkin AN, Monto AS, Kendal AP, Grigorieva EP, Burtseva EP, Rekstin AR, Beljaev AL, Bragina VE, Cox N, et al. (1993) Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis 168:881-887
71. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435-436
72. Shope RE (1931a) Swine influenza: I. Experimental transmission and pathology. J Exp Med 54:349-359
73. Shope RE (1931b) Swine influenza: III. Filtration experiments and etiology. J Exp Med 54:373-385
74. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ (1995) Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13:1399-1402
75. Smeenk CA, Brown EG (1994) The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J Virol 68:530-534
76. Smith W, Stuart-Harris CH (1936) Influenza infection of man from the ferret. Lancet 228:121-123
77. Smith WA, Andrewes C, Laidlaw P (1933) A virus obtained from influenza patients. Lancet 2:66-68
78. Stanley WM (1945) The preparation and properties of influenza virus vaccine concentrated and purified by differential centrifugation. J Exp Med 81:193-211
79. Steinhoff MC, Fries LF, Karron RA, Clements ML, Murphy BR (1993) Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. J Clin Microbiol 31:836-838
80. Subbarao K, Luke C (2007) H5N1 viruses and vaccines. PLoS Pathogens 3:e40
81. Tannock GA, Wark MC, Smith LE, Sutherland MM (1981) A clearance test in mice using non-adapted viruses to determine the immunogenicity of influenza strains. Arch Virol 70:91-101
82. Targonski PV, Poland GA (2004) Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly? Drugs Aging 21:349-359
83. Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL (2007) Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 13:426-435
84. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659
85. Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA (1994) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541-1544
86. Van Riel D, Munster VJ, De Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T (2007) Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 171:1215-1223
87. Wareing MD, Tannock GA (2002) Influenza update: vaccine development and clinical trials. Curr Opin Pulm Med 8:209-213
88. Webster RG (1966) Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol 97:177-183
89. Webster RG, Robinson HL (1997) DNA vaccines: a review of developments. BioDrugs 8:273-292
90. Webster RG, Kasel JA, Couch RB, Laver WG (1976) Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Infect Dis 134:48-58
91. Yetter RA, Barber WH, Small PA, Jr. (1980) Heterotypic immunity to influenza in ferrets. Infect Immun 29:650-653
92. Zhilova GP, Ignat'eva GS, Orlov VA, Malikova EV, Maksakova VL (1986) Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines. (1980-1983). Vopr Virusol 31:40-44